Vaxart Inc. [NASDAQ: VXRT] slipped around -0.39 points on Tuesday, while shares priced at $8.09 at the close of the session, down -4.60%. The company report on February 3, 2021 that Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate.
Study reached primary and secondary endpoints of safety and immunogenicity, respectively.
VXA-CoV2-1 induced potent CD8+ T-cell responses.
Vaxart Inc. stock is now 41.68% up from its year-to-date (YTD) trading value. VXRT Stock saw the intraday high of $8.50 and lowest of $7.85 per share. The company’s 52-week high price is 24.90, which means current price is +53.22% above from all time high which was touched on 02/02/21.
Compared to the average trading volume of 15.94M shares, VXRT reached a trading volume of 12067859 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Vaxart Inc. [VXRT]?
H.C. Wainwright have made an estimate for Vaxart Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 12, 2020. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on July 13, 2020, representing the official price target for Vaxart Inc. stock.
The Average True Range (ATR) for Vaxart Inc. is set at 2.11, with the Price to Sales ratio for VXRT stock in the period of the last 12 months amounting to 119.00. The Price to Book ratio for the last quarter was 6.63, with the Price to Cash per share for the same quarter was set at 1.19.
How has VXRT stock performed recently?
Vaxart Inc. [VXRT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.93. With this latest performance, VXRT shares gained by 10.22% in over the last four-week period, additionally sinking by -11.49% over the last 6 months – not to mention a rise of 635.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VXRT stock in for the last two-week period is set at 47.52, with the RSI for the last a single of trading hit 45.10, and the three-weeks RSI is set at 48.83 for Vaxart Inc. [VXRT]. The present Moving Average for the last 50 days of trading for this stock 8.11, while it was recorded at 8.53 for the last single week of trading, and 6.86 for the last 200 days.
Vaxart Inc. [VXRT]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Vaxart Inc. [VXRT] shares currently have an operating margin of -110.17. Vaxart Inc.’s Net Margin is presently recorded at -189.06.
Return on Total Capital for VXRT is now -33.85, given the latest momentum, and Return on Invested Capital for the company is -67.27. Return on Equity for this stock declined to -154.15, with Return on Assets sitting at -51.61. When it comes to the capital structure of this company, Vaxart Inc. [VXRT] has a Total Debt to Total Equity ratio set at 143.95. Additionally, VXRT Total Debt to Total Capital is recorded at 59.01, with Total Debt to Total Assets ending up at 50.35. Long-Term Debt to Equity for the company is recorded at 114.95, with the Long-Term Debt to Total Capital now at 47.12.
Reflecting on the efficiency of the workforce at the company, Vaxart Inc. [VXRT] managed to generate an average of -$1,331,786 per employee. Receivables Turnover for the company is 3.64 with a Total Asset Turnover recorded at a value of 0.27.Vaxart Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 13.20 and a Current Ratio set at 13.20.
Earnings analysis for Vaxart Inc. [VXRT]
With the latest financial reports released by the company, Vaxart Inc. posted -0.13/share EPS, while the average EPS was predicted by analysts to be reported at -0.13/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VXRT.
Insider trade positions for Vaxart Inc. [VXRT]
There are presently around $283 million, or 39.40% of VXRT stock, in the hands of institutional investors. The top three institutional holders of VXRT stocks are: STATE STREET CORP with ownership of 9,444,967, which is approximately 936.18% of the company’s market cap and around 0.10% of the total institutional ownership; VANGUARD GROUP INC, holding 5,163,182 shares of the stock with an approximate value of $41.77 million in VXRT stocks shares; and BLACKROCK INC., currently with $39.94 million in VXRT stock with ownership of nearly 15.511% of the company’s market capitalization.
Positions in Vaxart Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 86 institutional holders increased their position in Vaxart Inc. [NASDAQ:VXRT] by around 13,967,339 shares. Additionally, 56 investors decreased positions by around 15,738,247 shares, while 21 investors held positions by with 5,301,713 shares. The mentioned changes placed institutional holdings at 35,007,299 shares, according to the latest SEC report filing. VXRT stock had 42 new institutional investments in for a total of 2,417,953 shares, while 29 institutional investors sold positions of 6,603,379 shares during the same period.